Application no. and date | 13725157.5 (espacenet) (Federated) (European Patent Register), 20130527 | Patent/reg. no. and date | DK/EP 2854789, 20190626 | Publication date | 20150408 | Priority no. and date | EP 12170401, 20120601 | EP pub. no. and date |
EP 2854789 20150408 | Effective date | | Applicant/owner | Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1
51373 Leverkusen, DE | Applicant ref. no. | 1507977 | Inventor | WILLMANN, Stefan, Seidenweg 41
40593 Düsseldorf, DE, DICKSCHEN, Kristin, Cheruskerstr. 33
40545 Düsseldorf, DE, EIÃYING, Thomas, Kirschbaum 15
40764 Langenfeld, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/138 (2006.01) , A61P 35/00 (2006.01) | Title | GENOTYPE- ELLER FÆNOTYPE-BASEREDE LÆGEMIDDELFORMULERINGER | Int. application no. | EP2013060824 | Int. publication no. | WO2013178565 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|